Actively Recruiting
Observational Monocentric Study on Biliary Tract Cancer (BABEL)
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-08-26
560
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
BABEL is an observational, single-center, prospective study about patients affected by biliary tract cancers (BTC) treated at the Medical Oncology Unit of the FPUAG - IRCCS.
CONDITIONS
Official Title
Observational Monocentric Study on Biliary Tract Cancer (BABEL)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with biliary tract cancer
- Patients with radiological evident disease
- Patients >18 anni
- Written informed consent
- Patients with at least one oncological visit
You will not qualify if you...
- Patients without available clinical data
- Patients without histological diagnosis of BTC
- Patients without written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione Policlinico Universitario Agostino Gemelli/IRCSS - UOC di Oncologia Medica
Roma, Rome, Italy
Actively Recruiting
Research Team
L
Lisa Salvatore, MD, PhD
CONTACT
G
Giovanni Trovato, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here